Skip to content
AwardedSpainGoods€10,509,563

Suministro de Lanadelumab (DOE)

Published
Published 5 May 2026

Overview

Osakidetza (Basque Country Health Service) procured Lanadelumab, a pharmaceutical product, with an estimated value of approximately €10.5 million. Takeda Farmacéutica España, S.A. was awarded the contract on 30 April 2026 for €7.2 million, and the procurement is now complete.

Key details

Country
Spain
Status
Awarded
Category
Goods
Estimated value
€10,509,563
Procedure
Direct
Published
5 May 2026
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
€7,247,975
Award date
30 April 2026
Contract period
— → 29 April 2030
Winner
  • TAKEDA FARMACÉUTICA ESPAÑA, S.A.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    5 May 2026

Contracting authority

  • OSAKIDETZA - Servicio Vasco de Salud - Organización Central

    Procuring entity

    Vitoria-Gasteiz, Spain

    Authority website ↗

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Suministro de Lanadelumab (DOE) — won by TAKEDA FARMACÉUTICA ESPAÑA, S.A. — Skim